Glucocerebrosidase mutations in diffuse Lewy body disease()

Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson’s disease and Lewy body disorders. In the present study, we have identified GBA mutations in 6.8% (4/59) of cases with a pathological diagnosis of diffuse Lewy body...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Parkinsonism Relat Disord
Main Authors: Nishioka, Kenya, Ross, Owen A., Vilariño-Güell, Carles, Cobb, Stephanie A., Kachergus, Jennifer M., Mann, David M.A., Snowden, Julie, Richardson, Anna M.T., Neary, David, Robinson, Christopher A., Rajput, Alex, Papapetropoulos, Spiridon, Mash, Deborah C., Pahwa, Rajesh, Lyons, Kelly E., Wszolek, Zbigniew K., Dickson, Dennis W., Farrer, Matthew J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721925/
https://ncbi.nlm.nih.gov/pubmed/20971030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2010.09.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados